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Ebola virus (EBOV) can lead to severe hemorrhagic fever with a high risk of death
in humans and other primates. To guide treatment and prevent spread of the viral
infection, a rapid and sensitive detection method is required for clinical samples.
Here, we described and evaluated a reverse transcription loop-mediated isothermal
amplification (RT-LAMP) method to detect Zaire ebolavirus using the nucleoprotein gene
(NP) as a target sequence. Two different techniques were used, a calcein/Mn2+ complex
chromogenic method and real-time turbidity monitoring. The RT-LAMP assay detected
theNP target sequence with a limit of 4.56 copies/µL within 45 min under 61◦C, a similar
even or increase in sensitivity than that of real-time reverse transcription-polymerase
chain reaction (RT-PCR). Additionally, all pseudoviral particles or non- Zaire EBOV
genomes were negative for LAMP detection, indicating that the assay was highly specific
for EBOV. To appraise the availability of the RT-LAMP method for use in clinical diagnosis
of EBOV, of 417 blood or swab samples collected from patients with clinically suspected
infections in Sierra Leone, 307 were identified for RT-LAMP-based surveillance of EBOV.
Therefore, the highly specific and sensitive RT-LAMP method allows the rapid detection
of EBOV, and is a suitable tool for clinical screening, diagnosis, and primary quarantine
purposes.
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INTRODUCTION
The 2014 Ebola virus (EBOV) outbreak was the largest to date in West African countries (Frieden
et al., 2014; Hampton, 2014). It spread through direct contact with infected individuals, or by
touching the blood, organs, bodily secretions and ﬂuids, or the contaminated clothes of such people
(MacNeil and Rollin, 2012). Because the initial symptoms of ebolavirus infection can be confused
with those of other febrile illnesses such as endemic malaria (Chertow et al., 2014), and because the
infection cannot be detected rapidly in patients living in remote areas (World Health Organization
[WHO], 2014)1, the numbers of infected people and deaths were the highest yet recorded. To
control infection and to prevent further transmission during outbreaks of ﬁloviruses such as EBOV,
rapid detection is therefore essential (Grolla et al., 2005).
1http://www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/
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Current methods for the detection and diagnosis of
EBOV infection include virus isolation, electron microscopy,
immunohistochemistry (Zaki et al., 1999), enzyme-linked
immunosorbent assay testing (Niikura et al., 2001), reverse
transcription-polymerase chain reaction (RT-PCR), serologic
testing for IgM/IgG virus-speciﬁc antibodies (Ksiazek et al.,
1999a; Saijo et al., 2001), and point-of-care biosensors (Baca
et al., 2015). In general, when the EBOV viral load in the
blood gets to a higher case fatality rate, the detection of
antigens as a suitable method is used for laboratory diagnosis
(Fisher-Hoch et al., 1992; Ksiazek et al., 1999b). Thus, the
World Health Organization recommends real-time RT-PCR
as the ﬁrst choice for EBOV diagnosis. However, inhibitors
present in crude biological samples can inactivate the Taq
DNA polymerase used in PCR-based techniques (de Franchis
et al., 1988). Moreover, these methods are relatively complex
and require specialized instruments. Thus, to complement
PCR-based methods, another rapid, simple, and eﬀective assay is
needed.
Loop-mediated isothermal ampliﬁcation (LAMP) is a one-
step nucleic acid detection method developed by Notomi et al.
(2000) which relies on autocycling strand displacement DNA
synthesis. This novel method is highly speciﬁc and sensitive, takes
advantage of four or six speciﬁc primers to recognize six or eight
diﬀerent sequences of the target gene, and is performed under
isothermal conditions in less than 1 h using Bst DNA polymerase.
Furthermore, LAMP is less inﬂuenced by inhibitors present in
complex samples than standard PCR, which is highly beneﬁcial
for clinical specimens such as blood components, sputum, feces,
or body ﬂuids (Kaneko et al., 2007). LAMP assays have been
widely applied to genetic diagnoses, the detection of epidemic
bacteria (Hara-Kudo et al., 2005; Song et al., 2005) and viruses
(Okafuji et al., 2005), fetal sex identiﬁcation (Hirayama et al.,
2013), and parasite recognition (Chen et al., 2011; Kong et al.,
2012).
Kurosaki et al. (2007) developed a simple reverse transcription
loop-mediated isothermal ampliﬁcation (RT-LAMP) assay for
the detection of Zaire ebolavirus, targeting the trailer region of
the viral genome. However, this method has yet to be tested
in clinical samples. The EBOV genome is approximately 19 kb,
and encodes the following seven genes, which are ﬂanked by
untranslated regions: nucleoprotein (NP), viral structural protein
(VSP)35,VSP40, glycoprotein, VP30, VP24, and RNA-dependent
RNA polymerase (Ali and Islam, 2015).
NP is highly conserved among all EBOV species currently
known, and plays an important role in intracellular events
such as replication and transcription of the viral genome, and
nucleocapsid formation (Ali and Islam, 2015). It is therefore
recommended by the World Health Organization for use as a
target gene for the RT-PCR assay.
In the present work, we developed a point-of-care RT-LAMP
assay targeted to NP. Five sets of primers for the detection
of EBOV were designed and used in optimization of the RT-
LAMP assay. We also evaluated the speciﬁcity and sensitivity of
the LAMP method. Finally, 417 blood samples collected from
patients with clinically suspected infections were analyzed by
RT-LAMP and RT-PCR in clinical diagnosis.
MATERIALS AND METHODS
Viruses, RNA Extraction, and Preparation
of Templates
Twenty-six genomes of respiratory pathogens including artiﬁcial
RNAs of Sudan EBOV (Subtype Sudan, strain Gulu), Zaire
EBOV and MARV, SARS coronavirus, inﬂuenza A H7N9, H1N1,
H2N3, human parainﬂuenza viruses (PIV) type 1/2/3 and 4,
adenoviruses (ADV; serotype 3, serotype 5, and serotype 55),
respiratory syncytial virus infection RSVA/RSVB, MERS RNA,
human metapneumovirus HMPV, human coronavirus HCoV-
229E/ HCoV-OC43/HCoV-NL63, and HCoV-HKU1, bocavirus
BoV, as well as three respiratory bacterial pathogens such as
Legionella pneumophila 9135, Mycobacterium tuberculosis 005,
and Haemophilus influenza ATCC 49247 were used in this
study. Total viral RNAs were extracted from 200 µl of each
culture using a QIAamp viral RNA mini kit (Qiagen, Hilden,
Germany). All infectious materials were handled in biosafety level
3 facilities.
Preparation of Artificial EBOV RNA
Preparation of artiﬁcial EBOV RNA was performed as described
previously (Watanabe et al., 2004) with modiﬁcations. Brieﬂy,
663 kb NP fragments were synthesized (Sangon Biotech Co.,
Ltd., Shanghai, China) and cloned into vector pGEM-3Zf(+)
with inverse orientation of the T7 promoter sequence (Promega).
In vitro transcription of artiﬁcial EBOV RNA from NP subclones
was carried out using 50 U of T7 RNA polymerase (Promega)
in a 50-µl reaction volume according to the manufacturer’s
instructions. The RNA concentration was determined by
measuring the optical density at 260 nm (OD260), and the
RNA purity was determined by calculating the OD260/OD280
absorption ratio (ratios were ensured to be >1.8). RNA was then
dissolved in 20 µL DEPC-treated water, and stored at −70◦C
before use.
Primer Design
Based on the NP sequences of strain Mayinga deposited in
GenBank (accession no. AF086833), we selected potential target
regions and further analyzed the sequence using Primer Explorer
V4 software2 by aligning it with other species of EBOV. We
designed speciﬁc primer sets for the detection of EBO V in RT-
LAMP, with each set including an outer forward primer (F3), an
outer backward primer (B3), a forward inner primer (FIP), and a
backward inner primer (BIP) linked by a four thymidine spacer
(TTTT), which can recognize both sense and anti-sense strands.
To accelerate the RT-LAMP reaction, an additional loop primer
(LB) was designed. All primers were synthesized commercially
(Sangon Biotech Co., Ltd.).
RT-LAMP Assays
Reverse transcription loop-mediated isothermal ampliﬁcation
reactions were performed using a Loopamp RNA ampliﬁcation
kit (Eiken Chemical Co., Ltd., Tokyo, Japan) in a volume
2https://primerexplorer.jp/e/
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of 25 µL according to the manufacturer’s protocol. Each
reaction included 80 pmol of FIP and BIP, 40 pmol of
LB, 10 pmol of F3 and B3, and 2 µL template RNA. The
reaction was carried out at 61◦C for 60–80 min in dry bath
incubators.
Reverse transcription loop-mediated isothermal ampliﬁcation
ampliﬁed products were detected by turbidity monitoring as
well as visual observation. To assess turbidity, the amount of
white magnesium phosphate precipitate produced during the
LAMP reaction process was monitored using a Loopamp Real-
time Turbidimeter (LA-230; Eiken Chemical Co., Ltd., Tochigi,
Japan) recording the reaction curves at 650 nm every 6 s with
magnesium ion (Mg2+) in the reaction buﬀer (Mori et al., 2001).
For visual inspection, tubes containing 1 µl of ﬂuorescent calcein
were observed by the naked eye and photographed under natural
light or UV light at 365 nm. The color changed from orange to
green for a positive reaction, while the negative control remained
orange.
Real-time RT-PCR Assays
To illustrate RT-LAMP detection sensitivity, we targeted a region
of NP using the LiferiverTM EBOV Real Time RT-PCR Kit
(Shanghai ZJ BioTech Co., Ltd.) recommended by the World
Health Organization. Thermocycler conditions followed the
manufacturer’s instructions. During the ampliﬁcation process,
the ﬂuorescence intensity of the reporter dye (FAM) and a
quencher dye (TAMRA)was recorded to calculate the normalized
reporter signal, which is linked to the amount of product
ampliﬁed. The standard curve was drawn using the in vitro
transcribed RNA standard to calculate the number of RNA copies
in viral RNA extracts. The threshold cycle (Ct value) refers to the
number of ampliﬁcation cycles for the ﬂuorescence to reach the
threshold.
Clinical Specimens
A total of 417 clinical specimens from whole blood or
swabs were collected from patients thought to be infected by
EBOV during the outbreak in Sierra Leone, from 2014 to
2015. RT-LAMP assays and real-time RT-PCR were performed
simultaneously by the China Mobile Laboratory Testing Team
in Freetown, Sierra Leone. Information about the clinical
samples is listed in Supplemental Tables S1 and S2. This study
was carried out in accordance with the recommendations of
the Institute of Disease Control and Prevention, China with
written informed consent from all subjects. All subjects gave
written informed consent in accordance with the Declaration of
Helsinki.
RESULTS
Optimizing the RT-LAMP Assay
A total of ﬁve sets of primers were initially designed to detect
artiﬁcial EBOV RNA using the Real-time Turbidimeter. As
shown in Figure 1A, the EBL-2 primer set ampliﬁed NP in the
shortest time (∼10min), so this was chosen as the optimal primer
set for RT-LAMP detection of EBOV (Table 1).
FIGURE 1 | The most appropriate primers and reaction temperatures
for the reverse transcription loop-mediated isothermal amplification
(RT-LAMP) assay. Turbidity was monitored and recorded every 6 s for five
sets of primers used to amplify the target gene with a Loopamp real-time
turbidimeter at 650 nm. (A) A total of five sets of primers including EBL-1,
EBL-2, EBL-7, EBL-11, and EBL-16 were designed to detect artificial EBOV
RNA. (B) Reaction temperatures ranged from 53 to 67◦C with 2◦C intervals.
To further optimize the ampliﬁcation, we compared reaction
temperatures ranging from 53 to 67◦C with 2◦C intervals. The
most suitable reaction temperature range was shown to be
TABLE 1 | Sequence of primers used for specific amplification of NP.
Primer Type Sequence(5′–3′)
EBL-2F3 Forward outer GATGGAAGCTACGGCGAAT
EBL-2B3 Backward outer GTGAGGGCCTGGGACATT
EBL-2FIP Forward inner AGTGTCCTCGTCGTCCTCGTCTTAGAG
TTACTCGGAAAACGGC
EBL-2BIP Backward inner ATCGACCAAGGGTGGACAACAGTTTGTG
TCTGTCTGCCCTCTA
EBL-2LB Loop backward AAGAACAGTCAAAAGGGCCAGC
EBL-2LF Loop forward CCAAGTCATCTGGTGCATTCAT
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59–65◦C (Figure 1B), and 61◦C was ultimately chosen as the
optimal reaction temperature.
Specificity of NP Detection by RT-LAMP
To test the LAMP speciﬁcity for NP, we tested 26 non- Zaire
EBOV viruses in addition to EBOV itself and in vitro transcribed
artiﬁcial EBOV RNA as the positive control. Figure 2 shows that
EBOV RNA was identiﬁed positively by RT-LAMPwith the EBL-
2 primer set using turbidity monitoring and visual observation.
All non- Zaire EBOV strains tested negative, including the blank
control, indicating that the RT-LAMP method was speciﬁc for
EBOV.
Sensitivity of NP Detection by RT-LAMP
To determine the sensitivity of the RT-LAMP assay for EBOV,
a series of dilutions were prepared of artiﬁcial EBOV RNA
FIGURE 2 | Specificity of EBOV NP detection by RT-LAMP. (A) Turbidity
was monitored and recorded every 6 s by a Loopamp real-time turbidimeter
at 650 nm. (B) Visual detection using a calcein fluorescent detection reagent.
Lane 1, positive control (artificial EBOV RNA); lane 2, negative control
(double-distilled water); lane 3, Sudan EBOV (artificial Sudan EBOV RNA); lane
4, MARV (artificial MARV RNA); lane 5, SARS coronavirus; lane 6, H7N9; lane
7, H1N1; lane 8, H2N3; lanes 9–12, human parainfluenza viruses (PIV) 1, 2, 3,
and 4; lanes 13–15, adenoviruses (ADV; serotypes 3, 5, and 55); lanes 16 and
17, respiratory syncytial virus infection, RSVA, RSVB; lane 18, MERS RNA;
lane 19, human metapneumovirus, HMPV; lane 20, bocavirus, BoV; lanes
21–24, human coronavirus, HCoV-229E, HCoV-OC43, HCoV-NL63, and
HCoV-HKU1; lane 25, Legionella pneumophila 9135; lane 26, Mycobacterium
tuberculosis 005; and lane 27, Haemophilus influenza ATCC 49247.
FIGURE 3 | Comparison of RT-LAMP sensitivities in detecting EBOV
NP. Artificial EBOV RNA was serially diluted 10-fold from 4.56 × 104
copies/µL to 4.56 × 10−2 copies/µL. (A) Turbidity was monitored with a
Loopamp Realtime Turbidimeter at 650 nm every 6 s. (B) The reaction was
detected visually using a calcein fluorescent detection reagent. Artificial EBOV
RNA concentrations were: tube 1, 4.56 × 104 copies/µL; tube 2, 4.56 × 103
copies/µL; tube 3, 4.56 × 102 copies/µL; tube 4, 4.56 × 101 copies/µL;
tube 5, 4.56 copies/µL; tube 6, 4.56 × 10−1 copies/µL; tube 7, 4.56 × 10−2
copies/µL; tube 8, ddH2O.
ranging from 4.56 × 104 to 4.56 × 10−2 copies/µL. As shown
in Figure 3A, the times of positivity detection ranged from
18 min for 4.56 × 104 copies/µL to 36 min for 4.56 copies/µL
of virus RNA by real-time monitoring. Thus, the RT-LAMP
detection limit for NP is 4.56 copies/µL of artiﬁcial RNA in a
61◦C reaction lasting for 60 min. For the visual inspection, all
positive reactions changed to green while negative ones remained
orange under natural or 365 nm UV light (Figure 3B). These
data indicate that the sensitivity of the two detection methods
was the same. The detection limit of real-time RT-PCR for NP
was 4.56 copies/µL, but this was achieved with a higher Ct value
(Ct = 41). Thus, we concluded that the sensitivity of the RT-
LAMP assay for EBOV was similar or higher than real-time
RT-PCR.
Clinical Sample Detection
The 417 clinical blood or swab samples were simultaneously
analyzed by RT-LAMP and real-time RT-PCR. Of these, 307
patients were conﬁrmed to be infected with EBOV, while 106
tested negative (Figure 4 and Table 2). A higher Ct value
(Ct > 36) was recorded for the remaining four samples by
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FIGURE 4 | Visual detection of RT-LAMP findings of 413 patients with clinically suspected infections in Sierra Leone. Sample information is listed in
Supplemental Tables S1 and S2. A total of 307 positive (A) and 106 negative (B) samples were tested for EBOV infection by real-time RT-PCR and RT-LAMP. NC,
negative control (distilled water); PC, positive control (artificial EBOV RNA).
TABLE 2 | Reverse transcription loop-mediated isothermal amplification
(RT-LAMP) and real-time reverse transcription-polymerase chain reaction
(RT-PCR) findings of clinical blood or swab samples.
Results RT-LAMP Real-time RT-PCR
Positive samples 307 (Time: 10–30min) 307 (Ct ≤ 30)
Negative samples 106 (no change in color ) 106 (no peak)
RT-PCR, and green ﬂuorescence was observed after ∼45 min
by RT-LAMP, indicating a low level of EOBV RNA. We
suggested that these patients should be monitored for 2 weeks in
hospital.
DISCUSSION
Ebola virus has extremely high morbidity and mortality
levels in humans, it reemerged and caused an outbreak
in Western Africa where 28,476 suspected, probable, and
conﬁrmed cases, and 11,298 deaths were reported in Sierra
Leone up until Oct. 21 2015 according to Ebola Situation
Report fromWHO3). Although several chemical agents, vaccines,
and antibodies inhibit the spread of EBOV in humans
3http://apps.who.int/ebola/current-situation/ebola-situation-report-21
-october-2015
and animals, eﬀective therapies for clinical treatment are
scarce.
To combat the increasing incidence of EBOV infections,
we developed an RT-LAMP assay speciﬁc for EBOV diagnosis
using primers spanning the 663 bp NP sequence of the
viral genome. We found that the limit of detection for
this technique was 4.56 copies/µL, which compares with
13.4 copies/µL for the Real-Time RT-PCR assay using the
LiferiverTM-EBOV Kit according to the manufacturer’s
instructions. In comparison, the limit of detection was 10
RNA molecule standards targeting the nucleoprotein gene
by RT-PCR reported by Weidmann et al. (2004). In the
present work, the RT-LAMP assay showed an equivalent or
superior sensitivity to RT-PCR assays, indicating that it is
suﬃciently sensitive to detect low copy numbers of RNA.
Furthermore, the RT-LAMP assay showed a high level of
speciﬁcity, with no cross-reactivity with other species of
EBOV or other viruses. It was also comparable with real-time
RT-PCR at conﬁrming cases of EBOV infection in clinical
samples.
The RT-LAMP assay can detect the presence of virus in a
single step in which reverse transcription and DNA ampliﬁcation
proceed in a single tube at a constant temperature of 61◦C.
Compared with RT-PCR, the sensitivity of the RT-LAMP assay
is far greater in the presence of inhibitors. Moreover, RT-
LAMP primers speciﬁcally recognize target sequences using
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ﬁve independent target sequence regions, compared with RT-
PCR primers that recognize only two independent regions.
Therefore, the RT-LAMP assay is more suitable for the rapid
detection of NP in clinical samples.
CONCLUSION
We established a rapid and eﬀective visual RT-LAMP assay
targeting EBOV NP, which we showed to be extremely speciﬁc
and sensitive in the molecular diagnosis of EBOV infections.
It is a reliable tool for the identiﬁcation of EBOV, so could
be used as an alternative method of diagnostic testing at
clinical laboratories without the need for special apparatus.
Moreover, it can provide accurate results within 1 h, so may
be of use in the clinical diagnosis of EBOV in developing
countries.
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